ID
32630
Beschrijving
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form asks, if and when routine vaccine administrations have taken place and should be checked at visits 1-3.
Link
https://clinicaltrials.gov/ct2/show/NCT00241644
Trefwoorden
Versies (2)
- 01-11-18 01-11-18 -
- 09-11-18 09-11-18 - Sarah Riepenhausen
Houder van rechten
GlaxoSmithKline
Geüploaded op
9 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Routine Vaccine Administration
- StudyEvent: ODM
Beschrijving
Routine Vaccine Administrations
Alias
- UMLS CUI-1
- C2368628
- UMLS CUI-2
- C0205547
Beschrijving
If Yes is ticked, the above vaccines are not to be reported again in the Concomitant Vaccination section at the end of the CRF. Any other vaccines administered during the study period are to be recorded in the Concomitant Vaccination section at the end of the CRF.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032375
Beschrijving
OPV Vaccination Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0032375
- UMLS CUI [1,2]
- C0011008
Beschrijving
If Yes is ticked, the above vaccines are not to be reported again in the Concomitant Vaccination section at the end of the CRF. Any other vaccines administered during the study period are to be recorded in the Concomitant Vaccination section at the end of the CRF.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2240392
- UMLS CUI [1,2]
- C3653328
- UMLS CUI [1,3]
- C0012559
Beschrijving
DTPw-HB/Hib vaccination Date
Datatype
text
Alias
- UMLS CUI [1,1]
- C2240392
- UMLS CUI [1,2]
- C3653328
- UMLS CUI [1,3]
- C0012559
- UMLS CUI [1,4]
- C1115436
Similar models
Routine Vaccine Administration
- StudyEvent: ODM
C0205547 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C3653328 (UMLS CUI [1,2])
C0012559 (UMLS CUI [1,3])
C3653328 (UMLS CUI [1,2])
C0012559 (UMLS CUI [1,3])
C1115436 (UMLS CUI [1,4])